These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24183888)

  • 21. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
    Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
    J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance use in a population-based clinic sample of people with first-episode psychosis.
    Barnett JH; Werners U; Secher SM; Hill KE; Brazil R; Masson K; Pernet DE; Kirkbride JB; Murray GK; Bullmore ET; Jones PB
    Br J Psychiatry; 2007 Jun; 190():515-20. PubMed ID: 17541112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhalant abusers and psychiatric symptoms].
    Okudaira K; Yabana T; Takahashi H; Iizuka H; Nakajima K; Saito A
    Seishin Shinkeigaku Zasshi; 1996; 98(4):203-12. PubMed ID: 8710994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substance use in adolescence and psychosis: clarifying the relationship.
    Barkus E; Murray RM
    Annu Rev Clin Psychol; 2010; 6():365-89. PubMed ID: 20192802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and correlates of comorbidity 8 years after a first psychotic episode.
    Farrelly S; Harris MG; Henry LP; Purcell R; Prosser A; Schwartz O; Jackson H; McGorry PD
    Acta Psychiatr Scand; 2007 Jul; 116(1):62-70. PubMed ID: 17559602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of substance misuse in first-episode psychosis.
    Cantwell R; Brewin J; Glazebrook C; Dalkin T; Fox R; Medley I; Harrison G
    Br J Psychiatry; 1999 Feb; 174():150-3. PubMed ID: 10211169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
    Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
    J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depression and depressive symptoms in first episode psychosis.
    Romm KL; Rossberg JI; Berg AO; Barrett EA; Faerden A; Agartz I; Andreassen OA; Melle I
    J Nerv Ment Dis; 2010 Jan; 198(1):67-71. PubMed ID: 20061872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse.
    Møller T; Linaker OM
    Nord J Psychiatry; 2004; 58(3):237-42. PubMed ID: 15204212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substance Use in Patients With First-Episode Psychosis: Is Gender Relevant?
    Arranz B; Safont G; Corripio I; Ramirez N; Dueñas RM; Perez V; Alvarez E; San L
    J Dual Diagn; 2015; 11(3-4):153-60. PubMed ID: 26513726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using brief self-reports and clinician scales to screen for substance use disorders in psychotic patients.
    Møller T; Linaker OM
    Nord J Psychiatry; 2010 Apr; 64(2):130-5. PubMed ID: 19883188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
    Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
    J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-occurring psychotic and addictive disorders: neurobiology and diagnosis.
    Ross S; Peselow E
    Clin Neuropharmacol; 2012; 35(5):235-43. PubMed ID: 22986797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substance misuse and early psychosis.
    Tucker P
    Australas Psychiatry; 2009 Aug; 17(4):291-4. PubMed ID: 19301164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories.
    Iyer SN; Boekestyn L; Cassidy CM; King S; Joober R; Malla AK
    Psychol Med; 2008 Aug; 38(8):1147-56. PubMed ID: 18366823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-response relationship between number of comorbid anxiety disorders in adolescent bipolar/unipolar disorders, and psychosis, suicidality, substance abuse and familiality.
    Dilsaver SC; Akiskal HS; Akiskal KK; Benazzi F
    J Affect Disord; 2006 Dec; 96(3):249-58. PubMed ID: 16904187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Differences in the subjective effects of drugs in patients with a first psychotic episode. Preliminary results].
    Busquets E; Torrens M; Soler A; Farré M; Bulbena A
    Actas Esp Psiquiatr; 2005; 33(1):19-25. PubMed ID: 15704027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Psychosis and substance abuse].
    Vaz Carneiro S; Borrego M
    Acta Med Port; 2007; 20(5):413-22. PubMed ID: 18282438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study.
    Addington J; Addington D
    Acta Psychiatr Scand; 2007 Apr; 115(4):304-9. PubMed ID: 17355521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comorbidity of substance abuse and psychosis. Results of a multicenter study ].
    Matuszka B; Gerevich J
    Psychiatr Hung; 2009; 24(6):414-27. PubMed ID: 20190358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.